Study to Evaluate Safety, Tolerability & PK of rhNGF in Healthy Volunteers

NCT03836859 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
30
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Dompé Farmaceutici S.p.A

Collaborators